COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02901301
Recruitment Status : Active, not recruiting
First Posted : September 15, 2016
Last Update Posted : January 14, 2020
Information provided by (Responsible Party):
Hyun Cheol Chung, Yonsei University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 2020
Estimated Study Completion Date : October 2021